STOCK TITAN

Sale notice for 303,739 PACB (NASDAQ: PACB) shares filed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An investor in PACB filed a Rule 144 notice covering the planned sale of 303,739 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on 02/17/2026 on the NASDAQ market.

The filing lists an aggregate market value of 478,692.66 for the shares to be sold and notes that 301,907,431 shares of this class were outstanding. The seller acquired these shares as restricted stock from the issuer on 02/15/2026, with no special payment terms disclosed.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many PACB shares are included in this Rule 144 sale notice?

The notice covers the planned sale of 303,739 shares of PACB common stock. These shares were acquired as restricted stock from the issuer and are now being registered for potential resale under Rule 144 on the NASDAQ market.

What is the aggregate market value of the PACB shares in this Rule 144 filing?

The filing states an aggregate market value of 478692.66 for the 303,739 PACB shares to be sold. This figure reflects the total market value associated with the planned Rule 144 sale through the named broker on the NASDAQ exchange.

When were the PACB shares acquired and in what form?

The PACB shares were acquired on 02/15/2026 as restricted stock directly from the issuer. The filing lists the issuer as the source and describes the nature of payment as “Not Applicable,” indicating no special non-cash payment arrangement was disclosed.

How many PACB shares were outstanding relative to this Rule 144 sale?

The filing reports 301,907,431 PACB shares outstanding for the class involved. This number provides context for the planned sale of 303,739 shares, showing the relative size of the transaction versus the total shares outstanding at the time noted.

Which broker and exchange are involved in the planned PACB share sale?

The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, located in New York. The filing specifies that the 303,739 PACB common shares will be sold on the NASDAQ securities exchange, subject to Rule 144 conditions.

What representation does the selling PACB holder make in the Rule 144 notice?

By signing the notice, the selling holder represents that they do not know any undisclosed material adverse information about the issuer’s current or prospective operations. This statement is required in connection with the planned Rule 144 sale of the PACB shares.
Pacific Biosc

NASDAQ:PACB

PACB Rankings

PACB Latest News

PACB Latest SEC Filings

PACB Stock Data

516.26M
299.52M
Medical Devices
Laboratory Analytical Instruments
Link
United States
MENLO PARK